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Thyrotoxicosis is known to be associated with increased bone turnover and if prolonged can result in osteoporosis.' Ninety per cent of organic bone matrix is composed of type I collagen, Bone matrix components are released into the circulation and are measured in serum and urine as markers of bone collagen turnover.?
Kits are now available for use in the routine laboratory.
Type I collagen is synthesized as a precursor molecule, procollagen 1 and during its conversion to collagen, carboxyterminal propeptide of type I collagen (PICP) is released. Serum concentration of PICP is considered to be a measure of bone collagen formation. Carboxyterminal crosslinked telopeptide of type I collagen (ICTP) is a collagen breakdown product resulting from bone collagen degradation.'
In this study the effect of treatment of thyrotoxicosis on serum PICP and ICTP was examined.
PATIENTS AND METHODS
Twenty-two consecutive newly diagnosed thyrotoxic patients (five men and 17 women) were studied, Their ages ranged from 20 to 73 years. Six of the women were postmenopausal. Blood samples were taken for FT3 and TSH, PICP, ICTP and serum creatinine into monovettes with no anticoagulant. As ICTP is cleared by the kidney" patients with evidence of renal impairment were excluded from the study. There were no specific conditions for the blood sampling (i.e. patient fasting, time of day, etc.). Samples were taken before treatment (FT3 levels 8->43pmol/L, Ref range 3-5--7'3) and 6-31 weeks later (median 16) when the thyroid function had reverted to normal as judged by a FT3 Correspondence: Dr Hazel Wilkinson. 454 concentration within the reference range. PICP and rCTP were also measured in 22 age and sex matched euthyroid controls who had no symptoms or evidence of bone, endocrine disease or renal impairment.
PfCl' and ICTP concentrations were measured by radioimmunassay using commercial kits (Pharmacia Ltd, Milton Keynes, UK). Intra-assay and interassay coefficients of variation (CVs) for the PICP method were 2% and 6% at 102 J.tg/L and 266 J.tg/L, respectively. Intra-assay and interassay CVs for the ICTP assay were 5% and 4% at concentrations of 8·7 J.tg/L and 34·8 J.tg/L, respectively. Free T3 and TSH were measured by Kodak Clinical Diagnostics, Amerlex MAB FT3 and highly sensitive second generation coated tube methods, respectively. Creatinine was measured by an alkaline picrate method.
RESULTS
The .serum PICP concentration was significantly higher (mean 134, range 68-241/g/L) than in the controls in the thyrotoxic patients at presentation (mean 102, 75-146J.tg/L) (P<O·OOI). After treatment the concentration was still significantly higher (mean 155, 70-248 J.tg/L) than the controls (P < 0·00 I), but not significantly different from the pretreatment values (Fig. I) . The serum ICTP concentration in thyrotoxic patients (4'1-17'7 J.tg/L, mean 8,1) was significantly greater than in controls [2·Q--4·4J.tg/L, mean 3·2 (P<O·OOI)]. After treatment and becoming euthyroid ICTP concentration fell in all patients ( Fig. I) and were not significantly different from the controls.
There was no correlation between length of time to become euthyroid and change in marker concentrations.
DISCUSSION
Type I collagen is derived from the precursor molecule procollagen which is synthesized intracellularly and has propeptide extensions at both the aminoterminal and carboxyterminal ends of the molecule. Specific proteases cleave off the propeptides before the collagen molecules are assembled as fibres. The carboxyterminal end of the procoIlagen, known as carboxyterminal propeptide of type I collagen (PICP) is released into the blood with a stoichiometric ratio of I: I versus the collagen molecules incorporated in the extracellular matrix. This small study shows that serum PICP, a marker of new bone formation, increases when thyrotoxic patients become biochemically euthyroid. PICP is eliminated from the circulation mainly via the man nose receptors on liver endothelial cells. There is evidence to suggest that the thyrotoxic state by stimulating activity of the mannose receptors increases the elimination of PICP. 4 It may be that the increase in PICP observed here is due to reduced clearance and not to an increase in new bone formation. However, the PICP concentrations in the newly euthyroid patients were significantly higher than in the controls in all but four patients and above the established reference range in six patients, suggesting new bone formation. ICTP the carboxyterminal cross-linked telopeptide region of collagen type I is released into the serum as an immunologic intact fragment during degradation of collagen type I where it resists further degradation." This is the type I collagen precursor for the pyridinoline cross links that are measured in urine. As ICTP is relatively small in size it is cleared from the circulation by the kidneys. Renal failure increases the concentration of ICTP in serum." Serum ICTP correlates with bone resorption rate as determined histomorphometrically." This small study shows that bone resorption is increased in thyrotoxic patients and that it decreases on reverting to the euthyroid state.
We conclude that PICP and ICTP, markers of bone collagen turnover are sensitive to the effect of endogenous thyroid hormones. 
